ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 256926 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 256926; 2) Community: the network communities that were significantly associated with the response to NSC 256926; 3) Molecule: the relationships between components within communities and NSC 256926; 4) MDR: the compounds that were significantly associated with the NSC 256926.

NSC Compound Enrichment Correlation
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.00485717408280859 0.33334786
NSC 726217 Combretastatin A4-analogue 0.00485717408280859 0.28355162
NSC 732205 Null 0.00485717408280859 0.34750107
NSC 169434 component of Monistat cream 0.00485717408280862 0.10558437
NSC 625817 Null 0.0048681766467277 0.26622767
NSC 631534 Null 0.0048681766467277 0.3089116
NSC 637128 Null 0.0048681766467277 0.4440483
NSC 668298 Null 0.0048681766467277 0.29254249
NSC 678914 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride 0.0048681766467277 0.47445147
NSC 689138 1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 5-(1-methylethyl)-9-(phenylmethoxy)- 0.0048681766467277 0.20860254
Total:55  Current:7    [First] [Prev] [Next] [Last]